Synergistic effect of IgG4 antibody and CTLs causes tissue inflammation in IgG4-related disease.
IgG4-related disease (IgG4-RD) is characterized by multiorgan irreversible damage resulting from tissue-specific infiltration of IgG4+ plasma cells and cytotoxic T lymphocytes (CTLs). However, whether IgG4 antibody (Ab) contributes to the inflammation remains unclear. In this study, we established a mouse model enables to evaluate the pathogenic function of IgG4 Abs in response to a tissue-specific autoantigen using recombinant OVA-specific human IgG4 monoclonal Ab (rOVA-hIgG4 mAb) and the mice expressing OVA of the pancreatic islet (RIP-mOVA mice). We found no inflammatory effect of rOVA-hIgG4 mAb transfer alone, however, co-transfer with ovalbumin (OVA)-specific CD8 CTLs (OT-I T cells) induced a tissue damage with dense lymphocytic inflammation in the pancreas of RIP-mOVA mice. rOVA-hIgG4 mAb caused accumulation of conventional DC1 cells (cDC1s) in the lymphoid tissues, and the DCs activated the OT-I T cells via cross-presentation. We also revealed that the synergistic effects of CTLs and Abs were observed in the other subclasses including the endogenous Abs if they recognized the same antigen. The transfer of OVA-specific CD4 helper T cells (OT-II T cells) into RIP-mOVA mice induced the production of anti-OVA Ab, which had the synergistic effect, through acquisition of T follicular helper (TFH) phenotype. Moreover, using OT-II T cells deficient in Bcl6 caused less anti-OVA Abs production and inflammation with OT-I T cells. Our results indicated that autoreactive IgG4 Abs play an important role of the tissue-specific CTL response in IgG4-RD.